(Q42914416)

11 November 2017

title

Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria (English)

1 reference

11 November 2017

Ying-Lian Xiao

1

1 reference

11 November 2017

Sui Peng

2

1 reference

11 November 2017

Jin Tao

3

1 reference

11 November 2017

An-Jiang Wang

4

1 reference

11 November 2017

Jin-Kun Lin

5

1 reference

11 November 2017

Pin-Jin Hu

6

1 reference

11 November 2017

Min-Hu Chen

7

1 reference

11 November 2017

language of work or name

English

0 references

publication date

7 September 2010

1 reference

The American Journal of Gastroenterology

11 November 2017

published in

1 reference

11 November 2017

volume

105

1 reference

11 November 2017

issue

12

1 reference

11 November 2017

page(s)

2626-2631

1 reference

Functional gastroduodenal disorders

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

Prevalence of acid reflux in functional dyspepsia and its association with symptom profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.351

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.351

1 reference

11 November 2017

1 reference